MedTrace Logo

Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)

NCT05643729 · Status: SUSPENDED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-11-01

No results posted yet for this study

Summary

A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of Zofin for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).

Conditions

Interventions

DRUG

Zofin

Intravenous Infusion (IV) of Zofin

OTHER

Placebo

Intravenous Infusion of sterile saline

Sponsors & Collaborators

  • ZEO ScientifiX, Inc.

    lead INDUSTRY

Principal Investigators

  • Natasha Phrsai · Proxima

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2024-05-30
Completion
2024-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05643729 on ClinicalTrials.gov